An elevated serum level of transforming growth factor-beta 1 (TGF-beta 1) significantly correlated with lymph node metastasis and poor prognosis in patients with gastric carcinoma
H. Saito et al., An elevated serum level of transforming growth factor-beta 1 (TGF-beta 1) significantly correlated with lymph node metastasis and poor prognosis in patients with gastric carcinoma, ANTICANC R, 20(6B), 2000, pp. 4489-4493
Background: Overexpression of transforming growth factor betas (TGF-betas),
multifunctional polypeptides, have been reported in the tissue of various
types of carcinomas, including gastric carcinoma. To our knowledge, serum l
evels of TGF-beta1 have not previously been examined in patients with gastr
ic carcinoma as a possible indicator of prognosis. Methods. Preoperative se
rum levels of TGF-beta1 were measured in 111 patients with gastric carcinom
a by an enzyme-linked immunosorbent assay. Results: An elevated level of TG
F-beta1 was significantly correlated with lymph node metastasis and poor pr
ognosis. Moreover, the preoperative serum levels of TGF-beta1 in patients w
ith peritoneal recurrence were significantly higher than those in patients
both with lymph node recurrence and without recurrence. Conclusion: The ser
um level of TGF-beta1 might be useful for predicting recurrence patterns an
d prognoses in patients with gastric carcinoma.